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Abstract Purpose of this study was to establish a lecithin
nanoemulsion (LNE) without any synthetic surfactant as a
topical delivery vehicle and to evaluate its topical delivery
potential by the following factors: particle size, morphol-
ogy, viscosity, stability, skin hydration and skin penetra-
tion. Experimental results demonstrated that an increasing
concentration of soybean lecithin and glycerol resulted in a
smaller size LNE droplet and increasing viscosity,
respectively. The droplet size of optimized LNE, with the
glycerol concentration above 75% (w/w), changed from 92
(F10) to 58 nm (F14). Additionally, LNE, incorporated
into o/w cream, improved the skin hydration capacity of
the cream significantly with about 2.5-fold increase when
the concentration of LNE reached 10%. LNE was also
demonstrated to improve the penetrability of Nile red (NR)
dye into the dermis layer, when an o/w cream, incorporated
with NR-loaded LNE, applied on the abdominal skin of rat
in vivo. Specifically, the arbitrary unit (ABU) of fluores-
cence in the dermis layer that had received the cream with
a NR-loaded LNE was about 9.9-fold higher than the cream
with a NR-loaded general emulsion (GE). These observa-
tions suggest that LNE could be used as a promising topical
delivery vehicle for lipophilic compounds.
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Introduction
Topical delivery systems (TDS) have received increased
attention during the past few years. TDS could avoid a
variety of disadvantages compared with the oral adminis-
tration including drastic pH changes, deleterious presence
of food and enzymes and first-pass effect of the liver. TDS
also eschewed injection inconvenience and needle phobia.
In addition, TDS were noninvasive and can be self-
administered with the minimization of side-effects in the
topical drug therapy. However, the paucity of candidates
for TDS was presented in the market because few mole-
cules yielded skin permeability coefficients sufficiently
high to meet the clinical therapeutic needs, and TDS was
even less applicable for large hydrophilic molecules
because of their very low skin permeation rates. The con-
tinuous stratum corneum (the outer layer of skin) provided
a major barricade for drug penetration to the deeper skin
layers and was therefore the usual target for attempts to
strength topical drug permeation ability [1–5].
Various kinds of vesicular carriers had been suggested
as topical delivery vehicles, including liposomes, micro-
emulsions and lipid nanoparticles [6–10]. However, lipo-
some formulations had certain limitations such as drug
loading and stability. Microemulsions, which consisted of
synthetic surfactant, oil, water and co-surfactant, exhibited
a lower drug-loading capacity relative to the high con-
centration of surfactant, which had been generally
acknowledged to induce skin irritation [11, 12]. Recently,
due to advantages such as a controlled droplet size, lower
concentration of surfactant and the ability to efficiently
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solubilize lipophilic drugs, nanoemulsions, which were
composed of nanoscale droplets of one immiscible liquid
dispersed within another, had been widely designed to
deliver drugs by various routes of administration (e.g.,
intravenous, oral or ocular delivery) for therapeutic needs
[13–17]. Few studies reported nanoemulsions were used as
a topical carrier with following significant advantages
including powerful penetrability and a high drug-loading
capacity [18–21]. Most of nanoemulsions consisted of
synthetic surfactant, and nanoemulsions without any syn-
thetic surfactant were rarely reported.
In the present study, we report a LNE system without
any synthetic surfactant composed of snake oil [22], soy-
bean lecithin, glycerol and water. The effects of the glyc-
erol to water ratio and soybean lecithin concentration on
the emulsion’s physical properties (droplet size, viscosity,
morphology and stability) were studied. Furthermore, the
skin penetration ability and skin hydration levels of this




Soybean lecithin was purchased from Cargill Texturizing
Solutions Deutschland GmbH & Co. KG., USA. Refined
snake oil and o/w cream were obtained from Jiangsu
Longliqi Bioscience Co., Ltd., China. Nile red (NR) was
obtained from Sigma–Aldrich, USA. 2-Propanol and opti-
mal cutting temperature compound (OCT) were purchased
from Leica microsystem, German. Glycerol, ethane and
hexane were reagent grade.
Preparation of LNE
The LNE was composed of 15% (w/w) snake oil, soybean
lecithin at varying concentrations of 2.5, 5 and 7.5% (w/w)
and an aqueous glycerol solution with glycerol concentra-
tions of 0, 25, 50, 75 and 100% (w/w) as shown in Table 1.
Soybean lecithin was dissolved into the snake oil at 50 C.
The oil phase was then stirred in the glycerol aqueous
solution at 350 rpm and 50 C for about 10 min. The
mixture was emulsified by stirrer at 1,200 rpm for 2 min.
Subsequently, the pre-emulsion obtained was passed
through a high pressure homogenizer (NS1001L, Niro So-
avi, Italy) at a pressure of 1,000 bar for 4 cycles. Afterward,
the hot LNE was cooled to room temperature. Samples were
stored at 25 C for 180 days. To study their stability,
samples were stored in a sealed glass bottle at 25 C and
were evaluated in terms of droplet size at fixed times during
the first day, 90 and 180 days after the production day.
Droplet Size and Polydispersity Index (PI)
Droplet size and the PI of LNE were measured by photon
correlation spectroscopy (PCS; Zetasize 2000, Malvern
Instruments, UK). The LNE was diluted with deionized
water by 50-fold. Droplet size and PI value were obtained
as the average of three measurements at 25 C.
Viscosity Measurement
The viscosity of the LNE was measured using the small
sample adapter of a Brookfield rheometer (Model DV-III,
Brookfield Engineering Labs., Inc., Stoughton, MA, USA)
at 25 C. An average of three data points was obtained to
determine the viscosity at a shear rate of 7.34 s-1.
Morphology Measurement
Morphology of the LNE was characterized by freeze-fracture
transmission electron microscopy (FF-TEM). Samples were
immersed rapidly into liquid ethane cooled by liquid nitrogen.
They were then transferred into liquid nitrogen after about 5 s.
The samples, after being transferred into the chamber of the
freeze-etching apparatus (BALZERS BAF-400D), were
fractured at -120 C and 3 9 10-7 mbar. After being etched
for 1 min, Pt–C was sprayed onto the fracture face at 45, and
then C was sprayed at 90. The replicas were taken out of the
chamber and placed on a copper grid mesh after washing with
hexane. After processing, morphology data from the samples
were detected under a transmission electron microscope
(PHILIPS-FEI TECNAI20).
Table 1 Composition of LNE formulation






F1 15 2.5 0 82.5
F2 15 5 0 80
F3 15 7.5 0 77.5
F4 15 2.5 20.6 61.9
F5 15 5 20 60
F6 15 7.5 19.4 58.1
F7 15 2.5 41.25 41.25
F8 15 5 40 40
F9 15 7.5 38.75 38.75
F10 15 2.5 61.9 20.6
F11 15 5 60 20
F12 15 7.5 58.1 19.4
F13 15 2.5 82.5 0
F14 15 5 80 0
F15 15 7.5 77.5 0
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Skin Hydration Test
The skin hydration effect of LNE was investigated in a
blind, placebo-controlled in vivo study. LNE was stirred
into o/w cream at 200 rpm evenly at 40 C. Sample 1 was
o/w cream without LNE and samples 2, 3, 4 and 5 were o/w
cream enriched with 0.5, 2, 5 and 10% LNE (F12, shown in
Table 1), respectively. Fifteen volunteers applied the
samples on their healthy volar forearm skin. The skin
hydration test was conducted at 20 ± 2 C room temper-
ature and 50 ± 5% relative humidity. Samples were spread
on a 3.14 cm2 area of volar forearm skin with an amount
equaling 1.5 lL/cm2. After application, skin hydration was
measured at fixed time intervals of 30, 60, 90, 120 and
150 min with a Corneometer CM 825(CK Electronic
GmH, Germany). The percent change in skin hydration was
calculated with the following equation: D% = (Qt - Q0)/
Q0 9 100. Qt was the hydration value after application
time t, and Q0 was the hydration value before application.
Skin Penetration Test
Experiments were conducted on female Wistar SD rats
(180–200 g body weight). The rats were 10 weeks old and
were of a similar development stage. They were anesthe-
tized by a suitable dose of sodium barbital. The fur on the
abdominal area of the rats was carefully removed by an
electrical shaver to avoid damage to their stratum corneum.
The furless abdominal area was used for in vivo perme-
ation studies.
In this study, NR, a fluorescent dye, was dissolved into
the oil phase during the LNE preparation procedure. The
following two samples were used in a blind, placebo-con-
trolled in vivo study: one sample was the o/w cream
incorporated with NR-loaded LNE (F12, shown in
Table 1); the other was the o/w cream incorporated with
NR-loaded GE (F12 without HPH). The NR concentration
in the o/w cream was 2.5 lg/mL, and the NR-loaded GE or
NR-loaded LNE were stirred into the o/w cream at
200 rpm evenly at 40 C. For each set of experiments,
50 mg of sample was applied to the hairless abdominal
skin area of *3.14 cm2. At fixed times of 0.5, 2 and 4 h
after application, the surplus sample was removed from the
skin surface, the skin surface was washed three times with
PBS and dried gently under cold air with an electric hair-
drier. A 0.5 cm 9 0.5-cm skin piece, which was cut out
from the treated area, was embedded in optimal cutting
temperature compound and frozen rapidly by liquid nitro-
gen. The specimen was removed from liquid nitrogen and
was frozen on a metal block. The metal block was then
transferred to a cryostat microtome (LE ICACM 1850,
Germany) for slicing through vertical cross-sections of
skin. Twelve vertical skin sections with a thickness of
25 lm were obtained and stored at 4 C until analyzed
microscopically.
Skin sections were subjected to fluorescent microscopy
using an Olympus CK40 microscope (Olympus, Japan)
equipped with a UV source and filter for fluorescent
measurements. Image capture and analysis were carried out
by the Image-pro Plus program (Media Cybernetics, USA).
The excitation and emission wavelengths were 543 nm and
604 nm for NR, respectively. Images were recorded with a
camera integration time of 1/1.8 s, and the same parame-
ters were used for the imaging of all samples. The fluo-
rescence intensity value was quantified using Image-pro
Plus program.
Data Analysis
All the data tests were repeated three times and expressed
as the mean ± SD. The statistical data were analyzed by a
t-test analysis via Origin 7.0.
Results and Discussion
Particle Size and Viscosity of LNE
The mean droplet size of F1-F9 was in the range of 310–
100 nm with a PI value ranging from 0.6 to 0.2, while the
mean droplet size of F10-F15 was in the range of 100–
50 nm with a PI value from 0.2 to 0.1 (shown in Table 2).
Table 2 Droplet size, polydispersity index (PI) and viscosity of LNE





F1 309 ± 11 0.58 ± 0.09 2.3 ± 0.1
F2 282 ± 9 0.43 ± 0.06 5.2 ± 0.4
F3 240 ± 4 0.32 ± 0.05 12.1 ± 0.3
F4 238 ± 6 0.28 ± 0.04 11.6 ± 0.7
F5 212 ± 4 0.26 ± 0.03 15.2 ± 0.5
F6 182 ± 5 0.24 ± 0.03 32.3 ± 1.9
F7 163 ± 4 0.23 ± 0.04 24.1 ± 1.6
F8 145 ± 2 0.25 ± 0.03 43.6 ± 0.8
F9 113 ± 3 0.21 ± 0.02 71.2 ± 2.1
F10 92 ± 4 0.17 ± 0.03 68.4 ± 3.2
F11 79 ± 2 0.15 ± 0.04 83.2 ± 1.9
F12 68 ± 2 0.13 ± 0.02 136.7 ± 5.2
F13 71 ± 3 0.11 ± 0.01 565.7 ± 13.1
F14 58 ± 2 0.09 ± 0.03 989.6 ± 15.2
F15 75 ± 4 0.12 ± 0.05 1,574.8 ± 12.5
F12 (without
HPH)
1,742 ± 102 1.34 ± 0.21 375.2 ± 4.7
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An increase in soybean lecithin concentration from 2.5
to 7.5% (w/w) resulted in a decrease in particle size (mean
droplet size of F1-F3 were from 309 to 240 nm, mean
droplet size of F4-F5 were from 238 to 182 nm,
mean droplet size of F7-F9 were from 163 to 113 nm and
the mean droplet size of F10-F12 were from 92 to 68 nm)
at an increasing glycerol concentration except at glycerol
concentration of 100% (w/w), which pronounced an
increase in droplet size (from 58 to 75 nm) at a lecithin
concentration of 7.5% (w/w). The viscosity of LNE was
shown in Table 2, and the viscosity of LNE increased with
the increase in glycerol concentration and lecithin content.
When the glycerol concentration was less than 75%, the
viscosity was below 200 mPa s. However, when the glyc-
erol concentration was 100%, the viscosity signifi-
cantly increased, and the maximum viscosity reached
1,574.8 mPa s (F15). A possible explanation of the droplet
size reduction after an increased soybean lecithin concen-
tration and an increased glycerol content is that soybean
lecithin freely moved and was able to absorb around the
snake oil droplet, thereby resulting in an increased surface
to volume ratio of the droplet. Moreover, soybean lecithin,
localized to the surface of the emulsion particles, reduced
interfacial free energy and provided a mechanical barrier to
coalescence [23], while glycerol in the continuous aqueous
phase reduced the water’s surface tension. At a glycerol
concentration of 100%, an increased soybean lecithin
concentration resulted in a sharp increase in the viscosity of
the continuous aqueous phase, especially at a soybean
lecithin concentration of 7.5%. This high viscosity gener-
ated difficulty in lecithin movement and a rapid covering of
the oil droplet during the preparation procedure to prevent
any coalescence.
Interestingly, apart from the size and viscosity, the effect
of glycerol on the emulsion appearance was also observed.
When the formulation was composed of 0 and 25% (w/w)
glycerol in the aqueous phase (F1-F6), the nanoemulsion
appeared as a milky solution. When the formulation was
composed of 50% glycerol in the aqueous phase (F7-F9), the
nanoemulsion appeared as a semitransparent solution. Fur-
thermore, when the glycerol concentration was increased to
75 and 100% in the aqueous phase (F10-F15), the nano-
emulsion appeared as a transparent solution. Possibly,
glycerol behaved as a continuous phase solvent, whereby it
not only affected the appearance of the nanoemulsion but
also increased the viscosity of the continuous phase so as to
decrease the droplet collision frequency [24, 25].
Morphology of LNE
FF-TEM has emerged as an artifact-free method for
observing diverse systems such as surfactant aggregates,
polymer and polymer–surfactant solutions, and micro-
emulsions, as well as biological and biomedical systems.
These methods provide the ability to observe microstruc-
tures by rapid vitrification of the solution containing the
aggregates [26–28]. The morphology of the LNE
was observed with FF-TEM, but only micrographs of
Fig. 1 TEM micrograph of different LNEs. The images represent the LNE F2 (a), the LNE F5 (b), the LNE F8 (c), the LNE F11 (d) and the
LNE F14 (e)
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formulations of F2, F5, F8, F11 and F14 are shown in
Fig. 2. From all of the five images, only the formulation
with no glycerol (Fig. 1a) exhibited an irregular spherical
shape, and the distribution of the droplet size was uneven
with a large PI value (0.43), as confirmed by the PCS.
Furthermore, agglomeration of the droplet was present in
Fig. 1a. When 25% glycerol was added to the aqueous
phase, the sphere shape of the nanoemulsion became more
regular and smaller droplets were dominant (Fig. 1b).
When the concentration of glycerol increased sequentially,
the formulation exhibited a standard spherical shape, and
the distribution of droplet size became more homogenous.
In Fig. 1e, the droplet was in a standard spherical shape in
pure glycerol, and the distribution of droplet size was very
homogenous, as certificated by the PCS with a 0.09 PI
value. Form the above discussion, all the formulations were
in a spherical shape, and the extent was affected by the
glycerol concentration. As the concentration of glycerol
increased, the morphology of the LNE was more spherical
and the monodispersity of the LNE droplets was improved.
Stability of LNE
Droplet size was used as a stability index for all formula-
tions stored at 25 C for 180 days (Fig. 2). Most of the
formulations revealed an increase in droplet size with the
increasing concentration of glycerol. However, the size
change became undistinguishable when the concentration
of glycerol reached 100%. The formulation (F1–F5) mean
droplet size was significantly increased after 90 and
180 days of storage. Oswald ripening, the growth in the
size of droplets as the contents of one drop diffuses into
another, primarily affects nanoemulsions and is the most
serious instability concern for nanoemulsions. If there is
any diffusion of the contents of the dispersed phase, large
droplets grow larger at the expense of smaller droplets, and
the average size of the droplet distribution will continually
increase. For an o/w nanoemulsion, the rate of ripening is
directly related to the water solubility of the oil. In an ideal
situation with a perfectly monodispersed distribution, there
should be no ripening due to the lack of differences in the
solubility of droplets based on size. Thus, narrow distri-
butions will be more resistant to Oswald ripening than
broader distributions [21, 29, 30].
Skin Hydration of LNE
The results of the skin hydration assay are shown in Fig. 3.
After application, all the formulations increased the skin
hydration level. However, the formulation that contained
LNE improved the hydration more significantly than the
formulation without LNE, and changes in hydration levels
increased with the increasing concentration of LNE from
0.5 to 10%. After 150 min, changes in skin hydration were
24.5, 31.9, 39.3, 43.6 and 72.8% for formulations A, B, C,
D and E, respectively. One explanation for these effects is
that maybe nanoemulsion droplets adhere to the skin and
form a dense film that inhibits water evaporation from the
skin. Notably, nanoemulsions exhibit distinct adhesive
properties to skin surfaces. Hence, as the water evaporated
from the nanoemulsion dispersion area, a film formed of
nanoemulsion droplets stayed on the skin. The capillary
forces of the nanometer pores between the nanoemulsion
droplets are contractive and promote fusion and dense film
formation, which is also promoted by the application of
pressure [8, 31]. The absorption of some topically applied
drugs and cosmetics may be improved due to increased
skin hydration [32, 33].
Fig. 2 Stability of LNE size during storage at 25 C (mean ± SD,
n = 3)
Fig. 3 Effect of LNE on changes in skin hydration after incorporated
into o/w cream (mean ± SD, n = 3)
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Skin Penetration of LNE
Images of skin without applying any fluorescent dye
revealed a weak fluorescent signal, which was also con-
tributed to skin autofluorescence. However, the autofluo-
rescence signal was deducted when the photograph of the
skin slice (applied with NR dye) was taken. Figure 4a and b
depicts representative examples of fluorescence microscopy
images of vertically cross-sectioned skin following topical
application of the above two formulations for 0.5, 2 and 4 h.
Significantly, LNE with droplet sizes of about 68 nm
clearly promoted penetration of NR into the deeper layers of
skin when compared to a GE with a droplet size of about
1,742 nm. The intensity of the NR dye increased with time
until 4 h. Quantitative analysis of the dye penetration was
obtained from pixel intensities derived from fluorescence
measurements of skin slices. The dermis skin fluorescence
measurement of NR was expressed in arbitrary unit (ABU)
and is shown in Fig. 4c. A significant difference (p \ 0.01)
was detected in all the skin dermal layers between the above
two formulations. At fixation times of 0.5, 2 and 4 h, the
ABU value of fluorescence in the dermis layer that had
received the formulation with LNE was 3.7-, 7.3- and 9.9-
fold higher than the respective one with GE. The significant
extent of the skin penetration of the LNE formulation was
most likely attributed to the fact that nanoemulsions provide
superior skin hydration, which has been shown to be helpful
for improving permeation effects [34]. Assuming that the
average width of the transepidermal hydrophilic pathway is
up to *100 nm, which is similar to the intercorneocyte
space, it is conceivable that nanosized droplets are able to
traverse through the interconeocyte spaces [35, 36]. An
increase in the extent of penetration may result from an
alteration in the barrier properties and a greater degree of
partitioning of the lecithin nanoemulsion into the stratum
corneum [37]. In future studies, the mechanisms of lecithin
nanoemulsion penetration, cellular uptake, potential toxic-
ity in skin cells and the topical delivery of lipophilic drugs
should be investigated.
Conclusions
The LNE, composed of snake oil, soybean lecithin, glyc-
erol and water, was prepared by a HPH method success-
fully. Results revealed that LNE not only improved the
skin hydration of formulation significantly, but also greatly
strengthened skin penetration of NR for topical application.
LNE may be a promising topical delivery vehicle for
lipophilic compounds.
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